SOX9 and Alzheimer disease: Taken together one might hypothesize that lipid metabolism disruption associated with APOE4 can lead to an increase in SOX9 expression which could support astrocyte maturation and differentiation and availability in AD brain tissue, ultimately leading to disease progression.